This article is part of the supplement: 27th International Symposium on Intensive Care and Emergency Medicine
Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)
Critical Care 2007, 11(Suppl 2):P59 doi:10.1186/cc5219
No comments have yet been made on this article.